Additionally, CD44, a transmembrane glycoprotein associated with cancer stemness, exhibited a significant induction in its expression level upon CML treatment (Figure 3C, 3F). The gene discussed is CD44; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.